Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Alder on the establishment of Alder III
Mandate

Vinge has advised Alder on the establishment of Alder III

May 27, 2024 Private Funds

Vinge has advised Alder on the establishment of Alder's third and largest fund to date, Alder III.

Alder has successfully raised approximately SEK 3.1bn in investment commitments from an international investor base, doubling the total investor commitments as compared to its predecessor fund Alder II.

Alder closed its first fund in 2010 and focuses on investing in sustainable technology companies with profitable growth and a turnover of between SEK 100 and 750 million. Alder primarily invests as a majority shareholder in companies established in the Nordic region but may also invest selectively in the rest of Europe. Alder's funds - including Alder III - are classified as so-called Article 9 funds under the SFDR.

Vinge's team primarily consisted of Johan Larsson, Mattias Schömer, Martin Cronsioe, Viveka Classon, Nils Unckel, Ulf Nilsson, Emelie Svanberg, Anton Sjökvist, Semir Omerbasic, Tobias Onegård Karlsson, Marcus Andersson, Viktoria Wnuk, Emelie Zingmark, Helena Göransson,Kamyar Najmi and Nour Makie.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025